Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | EML3 |
Upstream (Parents) |
---|
(<<) FXYD3 → EML3 |
(<<) CDS1 → EML3 |
(<<) TAF4 → EML3 |
(<<) GALNT6 → EML3 |
(<<) TNFRSF8 → EML3 |
(<<) PTGES → EML3 |
Downstream (Children) |
---|
EML3 → C9orf68 (>>) |
EML3 → CDKL1 (>>) |
EML3 → COL2A1 (>>) |
EML3 → CRYBB2P1 (>>) |
EML3 → PAX1 (>>) |
EML3 → RBMY2FP (>>) |
EML3 → KRT36 (>>) |
EML3 → GFRA3 (>>) |
EML3 → PDCD1 (>>) |